Terrace Biotech, LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Francisco, CA
SAM.gov UEILS97QJ32YPD9
Terrace Biotech produces validated antibodies specific to human lung alveolar epithelial type 1 and type 2 cells, including anti HT1-56 and anti HT2-280. These antibodies are used in research applications including immunohistochemistry, western blotting, cell isolation by FACS, semi-quantitative dot blots, magnetic cell sorting, and TEM cryo-immunohistochemistry. The company serves research institutions and laboratories working with human lung tissue and cell biology.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Terrace Biotech, LLC | San Francisco | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.